2026. A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report. Journal of Pharma Insights and Research. 4, 2 (Apr. 2026), 252–258. DOI:https://doi.org/10.69613/ss2yp015.